Specifically, overactivation of EGFR signaling, caused by mutations in EGFR itself or in genes encoding downstream signal transducers, is known to contribute to the formation and progression of various cancer types in humans (Hsu and Hung, 2016; Rajaram et al., 2017; Sibilia et al., 2007). The gene discussed is EGFR; the disease is cancer.